1-20 of 190 < first | prev | | last >
  • 2010 Job and Satisfaction Survey

    These are challenging economic times and uncertain times for workers. Please tell us your thoughts and experiences as a professional in the pharmaceutical or biopharma industry. How do your position and salary compare with those of your peers? How has your job security changed within the past year? How are your companies and facilities managing change? The survey takes only a few minutes to complete, and all answers are completely confidential.

  • Therapeutic Dose: New Year, New Hope

    Pharma may not be adopting PAT and QbD wholesale, but smaller, more powerful hardware offers a glimmer of hope.

    Emil W. Ciurczak, Contributing Editor
  • Webcast: Tech Transfer: Do We Have a Failure to Communicate?

    Failure to transfer an analytical method or to move a process from lab to plant can cripple drug development efforts, wasting millions of dollars each year. Why do tech transfer projects fail? How can one ensure their success, whether one is transferring to another department or to a contract manufacturing organization? Join us for a controversial presentation and panel discussion of these issues.

  • Webcast: A Look Ahead: The Impact of Biosimilars on the Pharma Landscape

    Follow-on biologics, or biosimilars, will soon become reality in the U.S. Given their inherent complexity and the current state of analytics, how will their safety and quality be ensured? Will they boost or diminish competition and innovation in biotech? Join us for a thought-provoking presentation and panel discussion of these issues.

  • Pharmatech’s Chatterjee: Drug Manufacturing in the Future

    It is an interesting proposition: define what drug manufacturing will look like 20 years from now. There has never been a time when the portent for change has been so imminent.

    Bikash Chatterjee, President and CTO, Pharmatech Associates
  • Novavax’s Robinson: Taking Vaccines to the World

    Next Fall, Novavax expects to move to Phase III testing of its seasonal flu vaccine. In the meantime, it’s refining a manufacturing process that uses disposable process equipment to minimize risk, cost and plant footprint. VP Jim Robinson discusses the company’s plans.

    Agnes Shanley, Editor in Chief
  • Honeywell: The Future of the Plant Floor in a Wireless Environment

    A defining point for the wireless plant of the future will be the elimination of fixed workstations and hardwired controls and the introduction of modular equipment configurations.

    Jeff Becker, Director of Global Wireless Business, and Frank M. Offenbacher, Global Life Sciences Marketing Manager, Honeywell Process Solutions
  • Flexible Pharma: Puzzling Out the Plant of the Future

    The need to improve agility and reduce financial risk is driving new approaches to plant design and operation, and the use of new technologies. Industry experts look at the future pharmaceutical plant from all angles.

    Agnes Shanley, Editor in Chief, with Paul Thomas, Senior Editor
1-20 of 190 < first | prev | | last >